Deutsche Bank
LEGN icon

Deutsche Bank’s Legend Biotech LEGN Stock Holding History

Deutsche Bank’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.65M Buy
183,667
+9,674
+6% +$206K ﹤0.01% 1432
2026
Q2 		$5.02M Buy
173,993
+8,973
+5% +$242K ﹤0.01% 1382
2026
Q1 		$2.99M Buy
165,020
+7,986
+5% +$152K ﹤0.01% 1563
2025
Q4 		$3.41M Buy
157,034
+13,277
+9% +$380K ﹤0.01% 1500
2025
Q3 		$4.69M Buy
143,757
+19,780
+16% +$730K ﹤0.01% 1340
2025
Q2 		$4.4M Sell
123,977
-14,679
-11% -$476K ﹤0.01% 1299
2025
Q1 		$4.7M Buy
138,656
+3,589
+3% +$129K ﹤0.01% 1274
2024
Q4 		$4.4M Buy
135,067
+14,198
+12% +$588K ﹤0.01% 1398
2024
Q3 		$5.89M Buy
120,869
+237
+0.2% +$12.6K ﹤0.01% 1213
2024
Q2 		$5.34M Sell
120,632
-13,499
-10% -$623K ﹤0.01% 1222
2024
Q1 		$7.52M Sell
134,131
-4,388
-3% -$265K ﹤0.01% 1123
2023
Q4 		$8.33M Buy
138,519
+32,764
+31% +$2.08M ﹤0.01% 1068
2023
Q3 		$7.1M Sell
105,755
-126,601
-54% -$8.79M ﹤0.01% 946
2023
Q2 		$16M Buy
232,356
+84,278
+57% +$5.51M 0.01% 855
2023
Q1 		$7.14M Sell
148,078
-1,898
-1% -$92.8K ﹤0.01% 1092
2022
Q4 		$7.49M Sell
149,976
-63,900
-30% -$3.1M ﹤0.01% 1078
2022
Q3 		$8.73M Buy
213,876
+2,034
+1% +$95.5K 0.01% 1002
2022
Q2 		$11.7M Sell
211,842
-32,243
-13% -$1.36M 0.01% 944
2022
Q1 		$8.87M Buy
244,085
+34,258
+16% +$1.35M ﹤0.01% 1142
2021
Q4 		$9.8M Buy
209,827
+104,872
+100% +$5.32M ﹤0.01% 1118
2021
Q3 		$5.31M Buy
104,955
+97,285
+1,268% +$4.05M ﹤0.01% 1474
2021
Q2 		$314K Buy
7,670
+2,477
+48% +$84.2K ﹤0.01% 3519
2021
Q1 		$151K Hold
5,193
– – ﹤0.01% 3777
2020
Q4 		$147K Sell
5,193
-4
-0.1% -$115 ﹤0.01% 3633
2020
Q3 		$160K Sell
5,197
-243
-4% -$8.18K ﹤0.01% 3330
2020
Q2 		$232K Buy
+5,440
New +$213K ﹤0.01% 3070

Other funds holding LEGN

Matthews International Capital Management
Matthews International Capital Management San Francisco, California $241M AUM 42.66% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
IAMH
IvyRock Asset Management (HK) Sheung Wan, Hong Kong $190M AUM 21.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Empire Life Investments
Empire Life Investments Toronto, Ontario, Canada $1.83B AUM 33.18% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Deutsche Bank's LEGN Position: Q3 2026 in Review

Deutsche Bank increased its Legend Biotech (LEGN) stake by 5.6% in Q3 2026, buying an estimated $206K and bringing the position to 183,667 shares worth $3.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1432.

Deutsche Bank first reported a position in LEGN in Q2 2020 and has held it in 26 quarters since. The position peaked at $16M in Q2 2023. 75 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Deutsche Bank held 183,667 shares of Legend Biotech worth $3.65M as of Q3 2026.
  • Deutsche Bank bought 9,674 Legend Biotech shares in Q3 2026, an estimated $206K.
  • Legend Biotech made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1432 holding.
  • Deutsche Bank first reported a position in Legend Biotech in Q2 2020 and has held it in 26 quarters since.
  • Deutsche Bank's Legend Biotech position peaked at $16M in Q2 2023.
  • 75 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.